By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
Bright-eyed entrepreneurs with big ideas and even bigger fundraising needs have joined Digital RESI throughout 2021 in hopes of meeting investors who are just as excited to meet them, and there’s no virtual meeting spot that brings the two together like the Innovator’s Pitch Challenge (IPC). Apply to pitch at DIgital RESI November by October 22!
The IPC provides opportunities for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Fundraising entrepreneurs use the IPC for exposure, connection, valuable feedback, and often, a conversation that leads to many more down the road. Investors use it for the same – the opportunity to hear from and connect with entrepreneurs, learn more about exciting technology, and advance deal-flow initiatives.
For these reasons, the IPC is one of the most popular and well-attended features of the Digital RESI conference series, but don’t take our word for it. See what investors have said about their participation and check out previous investors that have sat on IPC judging panels throughout 2021.
 “It was a very economical use of time; the investors got to ask their important questions and the Innovators got a good idea of the most pressing questions from the investors point of view.”William Kuziel, MedPro Investors
 “The Pitch Sessions are a great opportunity to connect with startup CEOs and learn more about their work…It really has been an effective and efficient way to make connections, create deal flow and help startups raise money for their upcoming raises.”Mayank Taneja, OSF Healthcare
 “I look forward to LSN’s events because they provide an opportunity for our venture capital firm to find promising companies with exceptional technologies. The organization and technology platform make it very easy to hear numerous pitches from founders.”Nat Brinn, VC23
 “The Pitch Sessions were a great opportunity to engage with the CEO/Founders of very innovative Life Science startups. Despite the COVID-related transition from in-person to virtual meetings, the RESI team did an outstanding job organizing these sessions, ensuring that the live Q&A was very productive, and facilitating follow-up with these exciting companies.”Gary Gershony, Life Science Angels / BayMed Venture Partners
|
Previous 2021 Investor Judges
 |
 |
 |
 |
| Hamzeh Abdul-Hadi Hikma Ventures |
Aiden Aceves Vida Ventures |
Nuno Afonso Apogee Ventures |
Brent Ahrens Canaan Partners |
 |
 |
 |
 |
| Alexandra Amen BridgeBio |
Richard Anders Mass Medical Angels |
Bauke Anninga M Ventures |
Marc Appel Orange Grove Bio |
 |
 |
 |
 |
| Anjan Aralihalli CTI Life Sciences Fund |
Aimee Barkway Hadean Ventures |
Amine Benmoussa Apogee Ventures |
Attila Berces FastVentures |
 |
 |
 |
 |
| Sascha Berger TVM Capital Life Science |
Randy Berholtz Mesa Verde Venture Partners |
Reetika Bhardwaj ARCH Venture Partners |
Ivneet Bhullar Fusion Fund |
 |
 |
|
 |
| Yoann Bonnamour Mérieux Equity Partners |
Todd Brady Brace Pharma Capital |
Nat Brinn VC23 |
Ivan Burkov INKEF Capital |
 |
 |
 |
 |
| Cynthia Cai Viva BioInnovator |
Valerie Calenda Mérieux Equity Partners |
Anke Cassing High-Tech Gründerfonds |
Jeremy Chang BridgeBio |
 |
 |
 |
 |
| Benjamin Chen Panacea Ventures |
Kenneth Chew Vickers Venture Partners |
Poh Hui Chia Vickers Venture Partners |
Chinmay Chinmay BioIdeations |
 |
 |
 |
 |
| Elizabeth Cho-Fertikh Meda Angels |
Michel Chu Acorn Campus Taiwan |
Pablo Cironi Caixa Capital Risc |
Barbara Clarke Astia Angels |
 |
 |
 |
 |
| Darren Cooke Life Science Angels |
Peter Crane Outsized Ventures |
David Crean Mesa Verde Venture Partners |
Ruchi Dana Dana Group |
 |
 |
 |
 |
| Aldemar Degroot Biogen |
Niels Emmerich AbbVie Inc. |
Bettina Ernst BERNINA BioInvest |
Jemima Escamilla Research Corporation Technologies |
 |
 |
 |
|
| Naomi Fried Ambit Health Ventures |
Ryo Fujinami Shinsei Capital Partners |
Robert Garber 7wire Ventures |
Gary Gershony BayMed Venture Partners |
 |
 |
 |
 |
| Tom Gibbs Debiopharm Innovation Fund |
Sam Goldberger Ambit Health Ventures |
Gage Greening Medical Technology Enterprise Consortium (MTEC) |
Bryan Grulke Volcano Capital |
 |
 |
 |
 |
| Brian Hakim MedtecX |
Elaine Hamm Ascend BioVentures |
Z Haroon Julz Co LLC |
Christopher Haskell, Ph.D. Bayer |
 |
 |
 |
 |
| Michelle Ho 5AM Ventures |
Vivien Ho Pear Ventures |
Alan Hochberg Roche |
Dave Hood Medical Technology Enterprise Consortium (MTEC) |
 |
 |
 |
 |
| Dmitrij Hristodorov Forbion Capital Partners |
Adam Hunke Banner Venture Group |
Tomoko Ishikura Kicker Ventures |
Mishael Zohar OrbiMed Advisors LLC |
 |
 |
 |
 |
| I-Chien Jan Hukui Bio |
Allan Johnston Synergy Ventures |
Rick Jones BioAdvance |
Patrick Keenan Prevail Partners |
 |
 |
 |
 |
| Faisal Khan AstraZeneca |
John Kim Aphelion Capital, LLC |
Kristin King Boston Harbor Angels |
Merom Klein Keiretsu Forum |
 |
 |
 |
 |
| Pascal Krotee RiverVest Venture Partners |
Dmitry Kuzmin 4Bio Capital Partners |
Sebastien Latapie Dynamk Capital |
Zachary Leach Catalyst Health Ventures |
 |
 |
 |
 |
| Carla Lema Tomé Otsuka Pharmaceutical |
Elliot Levy DreamIt Health |
George Li Proxima Ventures |
Yatong Li Sixty Degree Capital |
 |
 |
 |
 |
| Xinhong Lim Vickers Venture Partners |
Debbie Lin Boehringer Ingelheim Venture Fund |
Don Lin Guoqian Venture Capital Investment |
Henry Lu China Merchants Capital |
 |
 |
 |
 |
| Benedikt Luhmann VI Partners |
Marc Martin-Casas Illumina Accelerator |
Tai Mei Meda Angels |
Andy Merken Burns & Levinson |
 |
 |
 |
 |
| Wouter Meuleman Illumina Ventures |
Junaid Mian SP8CEVC |
Sergio Montero Start-Up Chile |
Walter Moos Pandect Bioventures |
 |
 |
 |
 |
| Anesa Mulabecirovic Hadean Ventures |
Kim Nearing BVCF |
Justin Norden GSR Ventures |
Cédric Odje Debiopharm Innovation Fund |
 |
 |
 |
 |
| Michael O’Donnell Life Science Angels |
Marion Paolini Servier |
Nami Park Life Science Angels |
Francoise Perron-Sierra Servier |
 |
 |
 |
 |
| Dave Pinkowitz AnPac Bio |
Rohit Pratap Singh Xeraya Capital |
Mark Ralph Boehringer Ingelheim Venture Fund |
Varun Ramdevan Johnson & Johnson Innovation |
 |
 |
 |
 |
| David Ramos iGan Partners |
Richard Reschen MSD |
Stella Robertson Bios Partners |
Mel Rothberg Mira Life Science Ventures |
 |
 |
 |
 |
| Nikhil Sadhwani Individual Angel |
Caroline Sai Angels Santé |
Christina Salys Intuitive Surgical |
Diana Saraceni Panakes Partners |
 |
 |
 |
 |
| Barbara Schilberg BioAdvance |
Steve Seuntjens Personal Health Solutions |
Bryan Shao Keiretsu Forum |
Niels Sharman High-Tech Gründerfonds |
 |
 |
 |
 |
| Megan Shaw Innovation Works |
David Siet Amzak Health |
Mira Sirotic Keiretsu Forum |
Catello Somma TVM Capital Life Science |
 |
 |
 |
 |
| Jill Sorensen Medical Technology Enterprise Consortium (MTEC) |
Adarsh Sowcar NOVA |
Karen Spilizewski RiverVest Venture Partners |
Mark Springel Vida Ventures |
 |
 |
 |
 |
| Sanjay Srinivasan Accent Advisors |
Eran Steinberg Imaging Arts |
Kevin Sterling Keiretsu Forum |
Weiyong Sun Daiichi Sankyo |
 |
 |
 |
|
| Ben Sun Sand Hill Angels |
Haolin Sung Chaperone Investment |
Gayathri Swaminath GreenFire Bio, LLC |
Mayank Taneja OSF Healthcare Ventures |
 |
 |
 |
 |
| Mark Tang Good Health Capital |
Liz Todia Mutual Capital Partners |
Gadi Toren Robert Bosch Venture Capital |
Bill Trainor Mutual Capital Partners |
 |
 |
 |
 |
| Robert Tucci Texas Halo Fund |
Thomas Vogelsong KYTO Technology and Life Science |
Tad Weems Agilent Technologies |
Scott Weiner Amzak Health |
 |
 |
 |
 |
| Travis Whitfill Bios Partners |
Thierry Wurch Ipsen S.A. |
Jonathan Yeh Saisei Ventures |
John Yianni Earlybird |
 |
 |
 |
 |
| Alicia Yin 6 Dimensions Capital |
Derek Yuan LYFE Capital |
Yanxiang Zhou Illumina Ventures |
Anthony Zlaket UnityPoint Health Ventures |
Next Phase Newsletter 
Leave a Reply